13.66
price up icon4.35%   0.57
after-market After Hours: 12.00 -1.66 -12.15%
loading
Greenwich Lifesciences Inc stock is traded at $13.66, with a volume of 73,256. It is up +4.35% in the last 24 hours and down -0.58% over the past month. Greenwich LifeSciences Inc is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery. Its Product Candidates include; GP2, a HER2/neu transmembrane peptide that elicits a targeted immune response against HER2/neu-expressing cancers, GM-CSF Immunoadjuvant has been shown to enhance monocyte and neutrophil cytotoxicity against melanoma tumor cells and to enhance activity-dependent cellular cytotoxicity of monocytes and neutrophils against targets coated with the anti-ganglioside antibodies, and Cancer immunotherapy seeks to stimulate an individual's immune system to selectively attack cancer cells to inhibit the spread of cancer.
See More
Previous Close:
$13.09
Open:
$12.93
24h Volume:
73,256
Relative Volume:
2.44
Market Cap:
$163.98M
Revenue:
-
Net Income/Loss:
$-8.89M
P/E Ratio:
-19.51
EPS:
-0.7
Net Cash Flow:
$-6.48M
1W Performance:
-3.46%
1M Performance:
-0.58%
6M Performance:
-5.07%
1Y Performance:
+50.94%
1-Day Range:
Value
$11.89
$13.66
1-Week Range:
Value
$11.89
$14.79
52-Week Range:
Value
$8.00
$21.44

Greenwich Lifesciences Inc Stock (GLSI) Company Profile

Name
Name
Greenwich Lifesciences Inc
Name
Phone
203-434-3290
Name
Address
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Name
Employee
6
Name
Twitter
Name
Next Earnings Date
2024-11-08
Name
Latest SEC Filings
Name
GLSI's Discussions on Twitter

Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-01-21 Initiated H.C. Wainwright Buy

Greenwich Lifesciences Inc Stock (GLSI) Latest News

pulisher
Nov 01, 2024

(GLSI) Trading Report - Stock Traders Daily

Nov 01, 2024
pulisher
Nov 01, 2024

Form DEFA14A Greenwich LifeSciences, - StreetInsider.com

Nov 01, 2024
pulisher
Oct 23, 2024

Greenwich LifeSciences (NASDAQ:GLSI) Stock Price Up 3.1%Here's What Happened - MarketBeat

Oct 23, 2024
pulisher
Oct 22, 2024

(GLSI) On The My Stocks Page - Stock Traders Daily

Oct 22, 2024
pulisher
Oct 18, 2024

Great week for Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders who have 55% stake and they haven’t stopped buying - Simply Wall St

Oct 18, 2024
pulisher
Oct 18, 2024

There's Reason For Concern Over OneSpaWorld Holdings Limited's (NASDAQ:OSW) Price - Simply Wall St

Oct 18, 2024
pulisher
Oct 11, 2024

(GLSI) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Oct 11, 2024
pulisher
Oct 01, 2024

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Update - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Public Sector Pension Investment Board Acquires 4,434 Shares of Worthington Steel, Inc. (NYSE:WS) - Defense World

Oct 01, 2024
pulisher
Oct 01, 2024

Rhumbline Advisers Makes New Investment in Contineum Therapeutics, Inc. (NASDAQ:CTNM) - Defense World

Oct 01, 2024
pulisher
Sep 30, 2024

Greenwich LifeSciences CEO buys $21,945 in company stock - Investing.com India

Sep 30, 2024
pulisher
Sep 30, 2024

Greenwich LifeSciences CEO buys $21,945 in company stock By Investing.com - Investing.com Australia

Sep 30, 2024
pulisher
Sep 30, 2024

Insider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires 1,500 Shares of Stock - MarketBeat

Sep 30, 2024
pulisher
Sep 30, 2024

Snehal Patel Acquires 1,500 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Stock - Defense World

Sep 30, 2024
pulisher
Sep 27, 2024

12,295 Shares in Vanguard Mid-Cap ETF (NYSEARCA:VO) Acquired by Drucker Wealth 3.0 LLC - Defense World

Sep 27, 2024
pulisher
Sep 27, 2024

HEICO (NYSE:HEI-A) Stock Price Down 0.8% - Defense World

Sep 27, 2024
pulisher
Sep 27, 2024

Week Ahead (Apr.12- Apr.16): PDUFA Dates, Data Readouts (RCUS, ATXI, MRTX, KDNY…) - RTTNews

Sep 27, 2024
pulisher
Sep 27, 2024

PropTech Investment Co. II (OTCMKTS:PTICU) Shares Up 13.6% - Defense World

Sep 27, 2024
pulisher
Sep 23, 2024

George Church lab spawns $75m cell therapy startup - Longevity.Technology

Sep 23, 2024
pulisher
Sep 23, 2024

GC Therapeutics Raises $65M in Series A Funding - FinSMEs

Sep 23, 2024
pulisher
Sep 20, 2024

GC Therapeutics secures $65m to launch into off-the-shelf iPSC therapy space - Pharmaceutical Technology

Sep 20, 2024
pulisher
Sep 20, 2024

GC Therapeutics - The Pharma Letter

Sep 20, 2024
pulisher
Sep 19, 2024

(GLSI) Proactive Strategies - Stock Traders Daily

Sep 19, 2024
pulisher
Sep 19, 2024

Federated Hermes Inc. Trims Stock Holdings in Alibaba Group Holding Limited (NYSE:BABA) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Zacks Research Equities Analysts Raise Earnings Estimates for Toll Brothers, Inc. (NYSE:TOL) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

FY2024 EPS Estimates for Ero Copper Corp. Decreased by Analyst (NYSE:ERO) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Wilson Sonsini Advises GC Therapeutics on $65 Million Series A - Wilson Sonsini

Sep 19, 2024
pulisher
Sep 19, 2024

LPL Financial Holdings Inc. (NASDAQ:LPLA) to Post Q3 2025 Earnings of $4.74 Per Share, Zacks Research Forecasts - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Carvana Co. (NYSE:CVNA) Forecasted to Earn Q1 2025 Earnings of $0.48 Per Share - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Grafton Group Stake Shift Notified by GLG Partners - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

GCTx launches with bold cell therapy claim - The Pharma Letter

Sep 19, 2024
pulisher
Sep 19, 2024

Startup from George Church’s lab raises $75M to develop ‘supercell’ medicines - BioPharma Dive

Sep 19, 2024
pulisher
Sep 19, 2024

GCTx: Simplifying iPSC-based cell therapy production - BioCentury

Sep 19, 2024
pulisher
Sep 19, 2024

Insider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) VP Buys $11,080.00 in Stock - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Oppenheimer Asset Management Inc. Trims Stake in Encompass Health Co. (NYSE:EHC) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Zacks Research Weighs in on Alaska Air Group, Inc.’s Q1 2025 Earnings (NYSE:ALK) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

WINTON GROUP Ltd Makes New Investment in Diamondback Energy, Inc. (NASDAQ:FANG) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

WINTON GROUP Ltd Trims Stock Position in Republic Services, Inc. (NYSE:RSG) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Q1 2025 EPS Estimates for Centene Co. (NYSE:CNC) Reduced by Zacks Research - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

NVIDIA Co. (NASDAQ:NVDA) is Crew Capital Management Ltd.’s 9th Largest Position - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Arch Resources, Inc. to Post FY2025 Earnings of $18.39 Per Share, B. Riley Forecasts (NYSE:ARCH) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

WINTON GROUP Ltd Makes New $386,000 Investment in Ranger Energy Services, Inc. (NYSE:RNGR) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Robert Huizinga Buys 90,000 Shares of Kane Biotech Inc. (CVE:KNE) Stock - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy - BioSpace

Sep 19, 2024
pulisher
Sep 19, 2024

George Church launches stem cell programming start-up - Chemical & Engineering News

Sep 19, 2024
pulisher
Sep 19, 2024

From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform - Fierce Biotech

Sep 19, 2024
pulisher
Sep 19, 2024

‘Skin in the game’: Harvard geneticist George Church launches new stem cell company using his own skin cells - The Boston Globe

Sep 19, 2024
pulisher
Sep 18, 2024

Guardian Pharmacy Services, Inc. (GRDN) Plans to Raise $102 Million in September 26th IPO - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Guardian Pharmacy seeks to raise up to $108 mil in US IPO - AlphaStreet

Sep 17, 2024
pulisher
Sep 16, 2024

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) VP Jaye Thompson Buys 800 Shares - MarketBeat

Sep 16, 2024
pulisher
Sep 12, 2024

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders seem bullish, own 55% and have been buying more recently - Yahoo Finance

Sep 12, 2024

Greenwich Lifesciences Inc Stock (GLSI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):